Pharma-Bio Serv's EBIT per Share for the
three
months ended in Jan. 2024 was $-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.02.
During the past 12 months, the average EBIT per Share Growth Rate of Pharma-Bio Serv was -67.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -20.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pharma-Bio Serv's EBIT per Share or its related term are showing as below:
PBSV'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.3 Med: -13.05 Max: 111.9
Current: -20.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pharma-Bio Serv was 111.90% per year. The lowest was -45.30% per year. And the median was -13.05% per year.
PBSV's 3-Year EBIT Growth Rate is ranked worse than 82.73% of 498
companies
in the Healthcare Providers & Services industry
Industry Median: 7.75
vs PBSV: -20.40
Pharma-Bio Serv's EBIT for the
three
months ended in Jan. 2024 was $-0.44 Mil.
Pharma-Bio Serv EBIT per Share Historical Data
The historical data trend for Pharma-Bio Serv's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv (OTCPK:PBSV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pharma-Bio Serv EBIT per Share Related Terms
Thank you for viewing the detailed overview of Pharma-Bio Serv's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharma-Bio Serv (Pharma-Bio Serv) Business Description
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBSV has been successfully added to your 